Total Payments
$7,758
2024 Payments
$1,286
Companies
40
Transactions
263
Medicare Patients
2,725
Medicare Billing
$353,160
Payment Breakdown by Category
Food & Beverage$6,025 (77.7%)
Travel$1,581 (20.4%)
Other$100.00 (1.3%)
Education$52.48 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,025 | 248 | 77.7% |
| Travel and Lodging | $1,581 | 11 | 20.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $100.00 | 1 | 1.3% |
| Education | $52.48 | 3 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,087 | 30 | $0 (2024) |
| Olympus Corporation of the Americas | $809.03 | 7 | $0 (2017) |
| BOSTON SCIENTIFIC CORPORATION | $747.61 | 6 | $0 (2018) |
| Insmed, Inc. | $555.37 | 19 | $0 (2024) |
| GlaxoSmithKline, LLC. | $549.11 | 37 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $445.32 | 17 | $0 (2024) |
| United Therapeutics Corporation | $345.68 | 12 | $0 (2024) |
| Amgen Inc. | $345.62 | 11 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $326.49 | 14 | $0 (2023) |
| Grifols USA, LLC | $314.45 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,286 | 48 | AstraZeneca Pharmaceuticals LP ($352.34) |
| 2023 | $1,180 | 41 | AstraZeneca Pharmaceuticals LP ($314.46) |
| 2022 | $1,019 | 41 | Intuitive Surgical, Inc. ($241.41) |
| 2021 | $406.38 | 25 | Genentech USA, Inc. ($104.15) |
| 2020 | $731.12 | 35 | AstraZeneca Pharmaceuticals LP ($114.16) |
| 2019 | $854.85 | 26 | Boehringer Ingelheim Pharmaceuticals, Inc. ($204.62) |
| 2018 | $1,087 | 25 | BOSTON SCIENTIFIC CORPORATION ($747.61) |
| 2017 | $1,194 | 22 | Olympus Corporation of the Americas ($809.03) |
All Payment Transactions
263 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $33.18 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/09/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $8.30 | General |
| Category: Inflammation | ||||||
| 11/27/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.34 | General |
| Category: Immunology | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $115.59 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Pulmonology | ||||||
| 10/29/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Inflammation | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: RESPIRATORY | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $32.67 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 09/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Immunology | ||||||
| 09/04/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Inflammation | ||||||
| 08/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/17/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Pulmonology | ||||||
| 08/12/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 07/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/10/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $35.25 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/09/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: Respiratory | ||||||
| 06/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: RESPIRATORY | ||||||
| 06/19/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 707 | 1,026 | $287,211 | $79,512 |
| 2022 | 17 | 676 | 948 | $276,546 | $78,403 |
| 2021 | 18 | 603 | 956 | $307,293 | $89,720 |
| 2020 | 21 | 739 | 1,058 | $326,861 | $105,526 |
Total Patients
2,725
Total Services
3,988
Medicare Billing
$353,160
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 76 | 173 | $98,270 | $27,236 | 27.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 112 | 246 | $51,906 | $14,480 | 27.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 55 | 99 | $31,383 | $8,750 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 80 | $24,480 | $7,093 | 29.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 31 | $14,462 | $4,002 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $14,178 | $3,884 | 27.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 70 | 74 | $10,286 | $2,873 | 27.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 23 | $8,245 | $2,221 | 26.9% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 69 | 73 | $7,884 | $2,199 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 30 | $6,450 | $1,657 | 25.7% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 13 | 18 | $5,148 | $1,430 | 27.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 65 | 71 | $6,461 | $1,311 | 20.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 15 | 15 | $4,590 | $1,273 | 27.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 39 | 41 | $3,198 | $951.60 | 29.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 14 | 18 | $270.00 | $151.20 | 56.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 89 | 198 | $112,860 | $32,136 | 28.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 71 | 132 | $35,244 | $10,071 | 28.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 95 | 171 | $31,806 | $9,035 | 28.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $13,344 | $3,884 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 41 | $12,546 | $3,569 | 28.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 23 | $9,844 | $3,011 | 30.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 20 | $10,350 | $2,971 | 28.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 58 | 62 | $8,618 | $2,608 | 30.3% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 58 | 62 | $6,696 | $1,963 | 29.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 21 | 21 | $7,945 | $1,905 | 24.0% |
About Dr. Bashar Bargoty, MD
Dr. Bashar Bargoty, MD is a Pulmonary Disease healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2010. The National Provider Identifier (NPI) number assigned to this provider is 1780916775.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bashar Bargoty, MD has received a total of $7,758 in payments from pharmaceutical and medical device companies, with $1,286 received in 2024. These payments were reported across 263 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($6,025).
As a Medicare-enrolled provider, Bargoty has provided services to 2,725 Medicare beneficiaries, totaling 3,988 services with total Medicare billing of $353,160. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Knoxville, TN
- Active Since 02/02/2010
- Last Updated 12/05/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1780916775
Products in Payments
- EVIS EXERA (Device) $809.03
- TEZSPIRE (Biological) $743.29
- Arikayce (Drug) $507.32
- ULTRAFLEX (Device) $460.08
- XARELTO (Drug) $326.49
- TRELEGY ELLIPTA (Drug) $308.85
- FASENRA (Biological) $294.00
- GENERAL PULMONARY (Device) $287.53
- Prolastin-C Liquid (Biological) $266.84
- TYVASO (Drug) $245.68
- Da Vinci Surgical System (Device) $241.41
- ELIQUIS (Drug) $189.57
- OFEV (Drug) $188.83
- YUPELRI (Drug) $163.10
- DUPIXENT (Biological) $145.36
- Esbriet (Biological) $139.27
- Kcentra (Biological) $120.04
- NUCALA (Biological) $95.04
- Caldolor (Drug) $82.75
- BREO (Drug) $81.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Knoxville
Prof. Rajiv Dhand, Md, MD
Pulmonary Disease — Payments: $255,078
Pulmonary Disease $255,078
Dr. Varun Shah
Pulmonary Disease — Payments: $39,294
Pulmonary Disease $39,294
J. Turner, Md, MD
Pulmonary Disease — Payments: $15,733
Pulmonary Disease $15,733
Jared Kravitz, Md, MD
Pulmonary Disease — Payments: $8,913
Pulmonary Disease $8,913
Paul Branca, Md, MD
Pulmonary Disease — Payments: $8,504
Pulmonary Disease $8,504
Elise Schriver, M.d, M.D
Pulmonary Disease — Payments: $8,131
Pulmonary Disease $8,131